John G. Ullman & Associates’s QuidelOrtho QDEL Stock Holding History

John G. Ullman & Associates’s Portfolio QDEL Stock Details QDEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-11,600	Closed	-$855K	–	179
2023 Q4	$855K	Sell	11,600 -28,550	-71%	-$1.93M	0.14%	104
2023 Q3	$2.93M	Buy	40,150 +8,019	+25%	+$640K	0.48%	63
2023 Q2	$2.66M	Buy	32,131 +450	+1%	+$39.4K	0.41%	71
2023 Q1	$2.82M	Buy	31,681 +4,650	+17%	+$405K	0.44%	60
2022 Q4	$2.32M	Buy	27,031 +1,584	+6%	+$134K	0.37%	67
2022 Q3	$1.82M	Buy	25,447 +17,990	+241%	+$1.61M	0.32%	71
2022 Q2	$725K	Buy	+7,457	New	+$760K	0.12%	102

Other funds holding QDEL

Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

John G. Ullman & Associates's QDEL Position: Q1 2024 in Review

John G. Ullman & Associates sold out of QuidelOrtho (QDEL) in Q1 2024, closing a stake of 11,600 shares — an estimated $855K sold.

John G. Ullman & Associates first reported a position in QDEL in Q2 2022 and held it in 7 quarters. The position peaked at $2.93M in Q3 2023. 271 funds tracked by Wall St. Rank hold QDEL as of Q1 2024.

John G. Ullman & Associates reported no remaining QuidelOrtho position as of Q1 2024 after selling out during the quarter.
John G. Ullman & Associates sold 11,600 QuidelOrtho shares in Q1 2024, an estimated $855K.
John G. Ullman & Associates first reported a position in QuidelOrtho in Q2 2022 and held it in 7 quarters.
John G. Ullman & Associates's QuidelOrtho position peaked at $2.93M in Q3 2023.
271 funds tracked by Wall St. Rank held QuidelOrtho as of Q1 2024.

Based on John G. Ullman & Associates's 13F filing for Q1 2024, filed 6 May 2024.